Darin Vanderpool

1.9k total citations
12 papers, 395 citations indexed

About

Darin Vanderpool is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Darin Vanderpool has authored 12 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Darin Vanderpool's work include Herpesvirus Infections and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Chemical Synthesis and Analysis (2 papers). Darin Vanderpool is often cited by papers focused on Herpesvirus Infections and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Chemical Synthesis and Analysis (2 papers). Darin Vanderpool collaborates with scholars based in United States. Darin Vanderpool's co-authors include Stephen A. Margosiak, Christopher Pinko, Chen‐Chen Kan, Ping Chen, Hideaki Tsuge, Susumu Katoh, David A. Matthews, Robert J. Almassy, Richard E. Showalter and Jerry Meng and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Darin Vanderpool

12 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darin Vanderpool United States 8 203 146 72 51 44 12 395
Timothy S. Strutzenberg United States 13 463 2.3× 49 0.3× 66 0.9× 21 0.4× 32 0.7× 21 617
Nils Ostermann Switzerland 12 351 1.7× 33 0.2× 69 1.0× 69 1.4× 40 0.9× 24 514
Joseph Fowble United States 6 213 1.0× 73 0.5× 70 1.0× 105 2.1× 94 2.1× 6 569
Catherine Mazza France 13 571 2.8× 65 0.4× 44 0.6× 37 0.7× 162 3.7× 14 898
Frédéric Villard Switzerland 10 269 1.3× 38 0.3× 59 0.8× 24 0.5× 18 0.4× 14 504
R. B. Lingham United States 8 303 1.5× 82 0.6× 95 1.3× 81 1.6× 28 0.6× 10 469
Ana M. Mildner United States 8 435 2.1× 43 0.3× 51 0.7× 76 1.5× 21 0.5× 10 592
Canio J. Marasco United States 13 390 1.9× 81 0.6× 27 0.4× 103 2.0× 28 0.6× 18 558
David G. Osterman United States 13 510 2.5× 26 0.2× 48 0.7× 61 1.2× 48 1.1× 16 672
Sara M. Ø. Solbak Germany 14 312 1.5× 76 0.5× 19 0.3× 68 1.3× 24 0.5× 24 459

Countries citing papers authored by Darin Vanderpool

Since Specialization
Citations

This map shows the geographic impact of Darin Vanderpool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darin Vanderpool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darin Vanderpool more than expected).

Fields of papers citing papers by Darin Vanderpool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darin Vanderpool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darin Vanderpool. The network helps show where Darin Vanderpool may publish in the future.

Co-authorship network of co-authors of Darin Vanderpool

This figure shows the co-authorship network connecting the top 25 collaborators of Darin Vanderpool. A scholar is included among the top collaborators of Darin Vanderpool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darin Vanderpool. Darin Vanderpool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Waters, Laura, Ruth Aranda, Krystal Moya, et al.. (2024). Abstract 3319: The MTA-cooperative PRMT5 inhibitor, MRTX1719, demonstrates increased anti-tumor activity in combination with KRAS mutant-selective inhibitors in MTAP del,KRAS-mutant cancers. Cancer Research. 84(6_Supplement). 3319–3319. 2 indexed citations
2.
Aranda, Ruth, Laura Waters, Krystal Moya, et al.. (2023). Abstract 2778: A novel MTA-cooperative PRMT5 inhibitor, MRTX1719, stabilizes the ternary MTA-PRMT5 complex and leads to synthetic lethality in MTAP deleted cancers. Cancer Research. 83(7_Supplement). 2778–2778. 1 indexed citations
3.
Brown, Jason W., Zacharia S. Cheruvallath, Shawn M. O’Connell, et al.. (2023). Optimization of mTOR Inhibitors Using Property-Based Drug Design and Free–Wilson Analysis for Improved In Vivo Efficacy. ACS Medicinal Chemistry Letters. 14(11). 1544–1550. 1 indexed citations
4.
Cheruvallath, Zacharia S., Christopher M. McBride, Jun Feng, et al.. (2016). Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 1. Bioorganic & Medicinal Chemistry Letters. 26(12). 2774–2778. 12 indexed citations
5.
McBride, Christopher M., Zacharia S. Cheruvallath, J. David Lawson, et al.. (2016). Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2. Bioorganic & Medicinal Chemistry Letters. 26(12). 2779–2783. 18 indexed citations
6.
Vanderpool, Darin, Charles E. Grimshaw, J. David Lawson, & Jacques Ermolieff. (2014). Residence time and kinetic efficiency analysis of extracellular signal-regulated kinase 2 inhibitors. Analytical Biochemistry. 473. 46–52. 1 indexed citations
7.
Vanderpool, Darin, Ping Chen, Simon Bergqvist, et al.. (2009). Characterization of the CHK1 Allosteric Inhibitor Binding Site. Biochemistry. 48(41). 9823–9830. 37 indexed citations
8.
Barta, Nancy S., Chuangxing Guo, Judith G. Deal, et al.. (2006). Design, Synthesis, and Biological Activity of Novel Polycyclic Aza-Amide FKBP12 Ligands. Journal of Medicinal Chemistry. 49(3). 1202–1206. 18 indexed citations
9.
Kissinger, Charles R., Paul A. Rejto, Laura A. Pelletier, et al.. (2004). Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics. Journal of Molecular Biology. 342(3). 943–952. 82 indexed citations
10.
Chen, Ping, Hideaki Tsuge, Robert J. Almassy, et al.. (1996). Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic Triad. Cell. 86(5). 835–843. 119 indexed citations
11.
Margosiak, Stephen A., et al.. (1996). Dimerization of the Human Cytomegalovirus Protease:  Kinetic and Biochemical Characterization of the Catalytic Homodimer. Biochemistry. 35(16). 5300–5307. 65 indexed citations
12.
Pinko, Christopher, et al.. (1995). Single-chain Recombinant Human Cytomegalovirus Protease. Journal of Biological Chemistry. 270(40). 23634–23640. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026